Intel Capital invests million in medical artificial intelligence

Intel Capital injected $10 million into Lumiata, an analytics startup that focuses on medical artificial intelligence, the companies said.  Lumiata will be working on predictive analytics and artificial intelligence to improve risk and care management for organizations embracing population health management to ultimately drive more personalized care. “By integrating new data streams, such as IoT, with traditional clinical data, Lumiata has the potential to bring a fresh approach to managing risk with healthcare analytics,” Intel Health and Life Sciences general manager Steve Agritelley said in a statement. [Innovation Pulse: AI, cognitive computing, machine learning are coming. Best time to invest?] Lumiata said its Medical Graph combines data science with medical science and literature to model human pathophysiology to create the Lumiata Risk Matrix. The Lumiata Medical Graph is comprised of more…


Link to Full Article: Intel Capital invests million in medical artificial intelligence